» Articles » PMID: 25348469

Nattokinase: Production and Application

Overview
Date 2014 Oct 29
PMID 25348469
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Nattokinase (NK, also known as subtilisin NAT) (EC 3.4.21.62) is one of the most considerable extracellular enzymes produced by Bacillus subtilis natto. The main interest about this enzyme is due to its direct fibrinolytic activity. Being stable enough in the gastrointestinal tract makes this enzyme a useful agent for the oral thrombolytic therapy. Thus, NK is regarded as a valuable dietary supplement or nutraceutical. Proven safety and ease of mass production are other advantages of this enzyme. In addition to these valuable advantages, there are other applications attributed to NK including treatment of hypertension, Alzheimer's disease, and vitreoretinal disorders. This review tends to bring a brief description about this valuable enzyme and summarizes the various biotechnological approaches used in its production, recovery, and purification. Some of the most important applications of NK, as well as its future prospects, are also discussed.

Citing Articles

Novel Thermus thermophilus and Bacillus subtilis mixed-culture ferment extract provides potent skin benefits in vitro and protects skin from aging.

Wang J, Huang H, Tao K, Guo L, Hu X, Chang H J Cosmet Dermatol. 2024; 23(12):4334-4342.

PMID: 39161108 PMC: 11626318. DOI: 10.1111/jocd.16531.


Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Li X, Long J, Gao Q, Pan M, Wang J, Yang F Rev Cardiovasc Med. 2024; 24(8):234.

PMID: 39076715 PMC: 11266782. DOI: 10.31083/j.rcm2408234.


Partial purification and characterization of protease extracted from .

Khadka D, Pahadi T, Aryal S, Karki D Heliyon. 2024; 10(5):e27173.

PMID: 38463843 PMC: 10923713. DOI: 10.1016/j.heliyon.2024.e27173.


Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination.

Hulscher N, Procter B, Wynn C, McCullough P Cureus. 2023; 15(11):e49204.

PMID: 38024037 PMC: 10663976. DOI: 10.7759/cureus.49204.


Metal Nanomaterials and Hydrolytic Enzyme-Based Formulations for Improved Antifungal Activity.

Lyagin I, Aslanli A, Domnin M, Stepanov N, Senko O, Maslova O Int J Mol Sci. 2023; 24(14).

PMID: 37511117 PMC: 10379199. DOI: 10.3390/ijms241411359.